Abstract:Background: Circulating tumor cells (CTCs) have long been considered a reflection of tumor aggressiveness. Hematogenous spreading of CTCs from a primary tumor is a crucial step in the metastasis cascade, which leads ultimately to the formation of overt metastases. However, owing to the rarity of CTCs in peripheral blood, detecting these cells requires methods combined with high sensitivity and specificity, which sets tremendous challenges for the implementation of these assays into clinical routine. Methods: Generally, CTCs detection methods are composed of the following two steps: enrichment (isolation) process (morphological and immunological techniques) and detection (identification) process (cytometric and nucleic acid techniques), which may or may not be separate from enrichment. Genetic and molecular characterization of CTCs carried out by fluorescent in situ hybridization (FISH), comparative genomic hybridization (CGH), PCR-based techniques, and biomarker immunofluorescent staining extract more information about malignant profile, metastatic potential of CTCs, and the extent to which CTCs are genetically identical to the primary tumor. Results: Recent technical advances made it possible to detect CTCs. The efficacy of circulating tumor cell (CTC) detection among patients with solid malignancy has been investigated, which shows great potential to become a tool for real-time parameter of prognosis and serve as an early marker to assess the therapeutic response in overt cancers. Improvements in detection and characterization of CTCs will hopefully lead to refinement of clinical management of cancer patients. Conclusion: This review addresses the majority of assays that have been published thus far, including the enrichment and detection steps and the markers used in these assays, accompanied by some biological issues of CTC and the results of clinical application harvested.

A narrative review of circulating tumor cells clusters: A key morphology of cancer cells in circulation promote hematogenous metastasis

Circulating Tumour Cell Clusters: Isolation, Biological Significance and Therapeutic Implications

Circulating tumor cell clusters: Insights into tumour dissemination and metastasis

Key Characteristics of Circulating Tumor Cell Clusters and Implications for Cancer Metastases

Circulating tumor cells clusters and their role in Breast cancer metastasis; a review of literature

Better together: circulating tumor cell clustering in metastatic cancer

Specific study of biological tumor cytology: a narrative review

Circulating tumor cells: biology and clinical significance

Circulating Tumor Cell Clusters: United We Stand Divided We Fall

Circulating Tumor Cells (CTCs): A Unique Model of Cancer Metastases and Non-invasive Biomarkers of Therapeutic Response

Survival mechanisms of circulating tumor cells and their implications for cancer treatment

Circulating Tumor Cells: Biological Features and Survival Mechanisms

Perspective on Circulating Tumor Cell Clusters: Why It Takes a Village to Metastasize.

Research progress on the multi-omics and survival status of circulating tumor cells

Bring along your friends: Homotypic and heterotypic circulating tumor cell clustering to accelerate metastasis

Multi-omic features and clustering phenotypes of circulating tumor cells associated with metastasis and clinical outcomes

Origin, Metastasis, Harm, Recognition and Capture, and Elimination of Circulating Tumor Cells

Enrichment and Single-Cell Analysis of Circulating Tumor Cells.

Circulating tumor cells: advances in detection methods, biological issues, and clinical relevance

Circulating tumor cells in hepatocellular carcinoma: single-cell based analysis, preclinical models, and clinical applications.

Circulating Tumor Cells in Cancer Patients: Developments and Clinical Applications for Immunotherapy